Valens GroWorks acquired Valens Agritech as a wholly-owned subsidiary effective November 2016. Valens Agritech is a biotechnology company based in the Okanagan Valley of British Columbia focused on the cannabis cultivation and research business, with assets and improvements that include a state-of-the-art 17,000 square foot research and development facility in Kelowna. Valens is currently awaiting final inspection by the Regional Inspectorate of the Office of Controlled Substances, Health Canada for a Controlled Drugs and Substances Dealer's Licence (including the activities of , production (extraction), packaging, possession, sale, transportation, delivery and research), and also anticipates holding a Licensed Producer (“LP”) contract from Health Canada under the Access to Cannabis for Medical Purposes Regulations (ACMPR) as a separate application in due course. Valens is focused on deriving unique strains to alleviate different neurological conditions through intensive plant breeding, and to capitalize its position in the phytopharma world with the acquisition of a Health Canada DIN number. Stand 01.03.2017
WKN: A2ATFX ISIN: CA91931D1069 Kürzel: CSE:VGW in handelbar: Nein
Gründungsjahr: k.A. Haupthandelsplatz Vollzogene NamenswechselGenovation Capital - Land Angestellte: k.A.